Shanghai, China

Zhiyuan Cao

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Zhiyuan Cao in Cancer Therapy

Introduction: Zhiyuan Cao, based in Shanghai, China, is a prominent inventor with an impressive portfolio of 25 patents, primarily focusing on advancements in cancer therapy. His innovative research has significantly impacted the development of chimeric antigen receptor (CAR) T therapies, demonstrating potential in treating solid tumors.

Latest Patents: Among his notable patents, Zhiyuan Cao has recently developed compositions and methods for treating solid tumors using CAR T therapy. One of the key innovations includes the use of CAR comprising an extracellular domain that binds a Siglec protein or a receptor for the peptide hormone kisspeptin. Additionally, his work on enhancing T cell response and CAR cell expansion through genetically modified T cells has profound implications for immune therapy, involving a method where two CARs target different antigens simultaneously.

Career Highlights: Zhiyuan has made significant strides in the field of cellular therapeutics during his tenure with companies like Innovative Cellular Therapeutics Holdings, Ltd. and Innovative Cellular Therapeutics, Inc. His research plays a vital role in exploring and developing effective treatment options for challenging cancers.

Collaborations: Collaborating with other skilled professionals has been a hallmark of Zhiyuan’s career. Notable coworkers include Chengfei Pu and Lei Xiao, who have contributed to his research endeavors, enhancing the complexity and reach of his innovative therapies.

Conclusion: Zhiyuan Cao’s pioneering work continues to make a substantial impact on the field of cancer treatment. With a strong focus on CAR T therapy and enhancing T cell responses, he exemplifies the spirit of innovation that drives advancements in medical technology, ultimately aiming to improve patient outcomes in the battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…